ctrl K

GeneDx Corp. (WGS)

NASDAQ: WGS · Real-Time Price · USD

67.12

4.80 (7.70%)

At close: May 02, 2025, 3:59 PM

65.92

-1.79%

After-hours: May 02, 2025, 04:13 PM EDT

GeneDx Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	305.45M	202.57M	234.69M	212.19M	179.32M	196.17M
Cost of Revenue	111.05M	141.94M	261.44M	228.8M	175.3M	113.39M
Gross Profit	194.4M	60.62M	-26.75M	-16.6M	4.03M	82.78M
Operating Income	-23.21M	-163.66M	-667.65M	-446.15M	-241.99M	-30.41M
Interest Income	n/a	1.11M	2.54M	79K	506K	988K
Pretax Income	-52.63M	-176.69M	-598.03M	-245.39M	-241.34M	-29.7M
Net Income	-52.29M	-175.77M	-548.98M	-245.39M	-246.44M	-30.99M
Selling & General & Admin	168.48M	194.71M	338.24M	318.73M	163.93M	68.84M
Research & Development	45.72M	58.27M	86.2M	105.16M	72.7M	34.91M
Other Expenses	n/a	-28.69M	6.31M	5.66M	9.39M	9.45M
Operating Expenses	214.2M	224.28M	430.76M	429.55M	246.02M	113.2M
Interest Expense	-3.03M	n/a	3.21M	2.83M	2.47M	783K
Selling & Marketing Expenses	67.37M	60.96M	134.91M	112.74M	63.18M	39.35M
Cost & Expenses	325.26M	366.23M	692.2M	658.34M	421.32M	226.59M
Income Tax Expense	-343K	-926K	-49.05M	21.57M	5.1M	1.29M
Shares Outstanding (Basic)	26.89M	24.31M	10.24M	3.28M	155.48	7.28M
Shares Outstanding (Diluted)	26.89M	24.31M	10.24M	3.28M	1.68M	1.68M
EPS (Basic)	-1.94	-7.23	-53.63	-74.93	-1.58M	-4.26
EPS (Diluted)	-1.94	-7.23	-53.63	-74.93	-146.94	-18.48
EBITDA	-23.21M	-136.46M	-398.2M	-219.19M	-224.73M	-22.51M
EBIT	-55.66M	-170.19M	-457.51M	-242.56M	-238.87M	-28.92M
Depreciation & Amortization	n/a	33.73M	63.03M	23.36M	14.13M	6.41M